| ISIN | AT0000A1FNT0 | 
|---|---|
| Valor Number | 28871817 | 
| Bloomberg Global ID | |
| Fund Name | DSC Equity Fund – Healthcare A|A | 
| Fund Provider | 
                                            
                                            
                                            Dreyfus Söhne & Cie AG, Banquiers
                                            
    
        Aeschenvorstadt 16 | Postfach 4051 Basel Schweiz Phone: +41 61 286 66 66 Web: https://www.dreyfusbank.ch  | 
                                    
| Fund Provider | Dreyfus Söhne & Cie AG, Banquiers | 
| Representative in Switzerland | 
                                            Dreyfus Söhne & Cie AG, Banquiers Basel  | 
                                    
| Distributor(s) | 
                                            
                                                Dreyfus Söhne & Cie AG, Banquiers Basel  | 
                                    
| Asset Class | Equities | 
| EFC Category | |
| Distribution Policy | Distribution | 
| Home Country | Austria | 
| Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) | 
| Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) | 
| Investment Strategy *** | N/A | 
| Peculiarities | 
| Current Price * | 203.26 CHF | 03.11.2025 | 
|---|---|---|
| Previous Price * | 203.22 CHF | 31.10.2025 | 
| 52 Week High * | 237.48 CHF | 04.03.2025 | 
| 52 Week Low * | 186.68 CHF | 08.08.2025 | 
| NAV * | 203.26 CHF | 03.11.2025 | 
| Issue Price * | 209.36 CHF | 03.11.2025 | 
| Redemption Price * | 203.26 CHF | 03.11.2025 | 
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 38,219,823 | |
| Unit/Share Assets *** | 36,600,033 | |
| Trading Information SIX | ||
| YTD Performance | -9.21% | 
        30.12.2024 - 03.11.2025
        30.12.2024 03.11.2025  | 
                                    
|---|---|---|
| 1 month | -0.16% | 
        03.10.2025 - 03.11.2025
        03.10.2025 03.11.2025  | 
                                    
| 3 months | +8.03% | 
        04.08.2025 - 03.11.2025
        04.08.2025 03.11.2025  | 
                                    
| 6 months | -1.44% | 
        05.05.2025 - 03.11.2025
        05.05.2025 03.11.2025  | 
                                    
| 1 year | -12.80% | 
        04.11.2024 - 03.11.2025
        04.11.2024 03.11.2025  | 
                                    
| 2 years | -2.07% | 
        03.11.2023 - 03.11.2025
        03.11.2023 03.11.2025  | 
                                    
| 3 years | -13.07% | 
        03.11.2022 - 03.11.2025
        03.11.2022 03.11.2025  | 
                                    
| 5 years | -0.01% | 
        03.11.2020 - 03.11.2025
        03.11.2020 03.11.2025  | 
                                    
| Equity Participation Rate in % | 96.46 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | 0.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| iShares MSCI Wld HlthCrSect AdvcdETF$Inc | 9.64% | |
|---|---|---|
| Johnson & Johnson | 7.25% | |
| Eli Lilly and Co | 6.31% | |
| Abbott Laboratories | 4.61% | |
| AbbVie Inc | 4.57% | |
| UnitedHealth Group Inc | 3.97% | |
| Merck & Co Inc | 3.30% | |
| AstraZeneca PLC | 3.21% | |
| Novartis AG Registered Shares | 2.77% | |
| Sanofi SA | 2.69% | |
| Last data update | 30.09.2025 | |
| TER | 1.49% | 
|---|---|
| TER date | 30.04.2025 | 
| Performance Fee *** | |
| PTR | |
| Max. Management Fee *** | 1.50% | 
| Ongoing Charges *** | 1.49% | 
| 
                                            SRRI ***
                                             | 
                                    |
| SRRI date *** | 31.10.2025 |